A detailed history of Bray Capital Advisors transactions in Sanofi stock. As of the latest transaction made, Bray Capital Advisors holds 4,075 shares of SNY stock, worth $226,081. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,075
Previous 4,075 -0.0%
Holding current value
$226,081
Previous $198,000 0.51%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020

SELL
$44.25 - $50.86 $22,125 - $25,430
-500 Reduced 10.93%
4,075 $205,000
Q2 2019

Jul 29, 2019

BUY
$40.43 - $44.3 $28,301 - $31,009
700 Added 18.06%
4,575 $198,000
Q1 2018

May 04, 2018

BUY
$38.98 - $45.76 $151,047 - $177,320
3,875 New
3,875 $155,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $139B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.